Alzheimer's disease

AbbVie cans Voyager Alzheimer’s, Parkinson’s gene therapy pacts
Fierce Biotech
Tue, 08/4/20 - 11:07 am
AbbVie
Alzheimer's disease
Parkinson's Disease
Voyager Therapeutics
Roche doubles down on Tau
EP Vantage
Wed, 07/29/20 - 12:20 pm
Roche
anti-tau antibodies
UCB Pharma
UCB01017
Alzheimer's disease
Scientists get closer to blood test for Alzheimer’s disease
Stat
Tue, 07/28/20 - 07:06 pm
diagnostics
Alzheimer's disease
Eli Lilly
Alzheimer’s catalysts round off a year dominated by Biogen
EP Vantage
Fri, 07/17/20 - 11:17 am
Alzheimer's disease
Roche
Eli Lilly
AC Immune
Biohaven
Cortexyme
Biogen
AC Immune's Tau Vaccine for Alzheimer's Advanced into Phase Ib/II Clinical Trials
BioSpace
Thu, 07/16/20 - 11:20 pm
AC Immune
clinical trials
ACI-35.030
Alzheimer's disease
Biogen and Eisai trial drug in asymptomatic Alzheimer’s disease
Pharmaforum
Tue, 07/14/20 - 10:31 am
Biogen
Eisai
Alzheimer's disease
amyloid
BAN2401
clinical trials
Alzheimer’s Drugs on Verge of Becoming Mainstream Medicine, but Early Intervention Still is Needed
BioSpace
Thu, 07/9/20 - 10:27 pm
Alzheimer's disease
drug development
diagnostics
aducanumab
Biogen
Biogen Alzheimer’s Drug in FDA’s Court Following Completion of Filing
Xconomy
Thu, 07/9/20 - 12:12 am
Biogen
FDA
aducanumab
Alzheimer's disease
Amylyx Pharmaceuticals nabs $30M for ALS, Alzheimer's work
Fierce Biotech
Thu, 07/2/20 - 11:11 am
Amylyx Pharmaceuticals
funding
ALS
Alzheimer's disease
Presented with upbeat Alzheimer's agitation data, FDA sees another 'breakthrough' in Axsome's AXS-05
Endpoints
Sat, 06/27/20 - 11:37 pm
Axsome Therapeutics
Alzheimer's disease
AXS-05
major depressive disorder
After Disappointing Study Results, Denali and Sanofi Shift Resources to a Different Alzheimer's Drug
BioSpace
Thu, 06/11/20 - 10:49 pm
Denali Therapeutics
Sanofi
DNL747
ALS
Alzheimer's disease
DNL788
clinical trials
Can a small biotech successfully tackle an Everest climb like Alzheimer’s? Athira has $85M and some influential backers ready to give it a shot
Endpoints
Sat, 06/6/20 - 03:08 pm
Alzheimer's disease
Athira Pharma
clinical trials
Lilly wins first-ever FDA approval for drug that can spot Alzheimer's 'tau tangles'
BioPharma Dive
Fri, 05/29/20 - 12:17 pm
Eli Lilly
FDA
Alzheimer's disease
R&D
tau tangles
Tauvid
imaging
diagnostics
PhII Alzheimer's data looming, Shionogi spending up to $500M on a buyout involving one of the toughest bets in biotech
Endpoints
Tue, 05/26/20 - 12:02 pm
Shionogi
Alzheimer's disease
Tetra Therapeutics
M&A
Fresh off positive Nuplazid data, Acadia adds new clinical drug from Vanderbilt in milestone-heavy deal
Endpoints
Fri, 05/8/20 - 10:43 am
Acadia Pharma
Vanderbilt
Nuplazid
drug development
Alzheimer's disease
Parkinson's Disease
Biogen gears up Swiss manufacturing facility for potential aducanumab rollout
Fierce Pharma
Thu, 05/7/20 - 10:17 pm
Biogen
Alzheimer's disease
aducanumab
FDA
drug manufacturing
Has Biogen Found the Answer to Treating Alzheimer's?
Motley Fool
Fri, 05/1/20 - 11:07 am
Biogen
FDA
Alzheimer's disease
aducanumab
Axsome shares rocket up on a surprise win for late-stage Alzheimer’s agitation study — but this is no easy layup
Endpoints
Mon, 04/27/20 - 09:42 am
Axsome Therapeutics
Alzheimer's disease
clinical trials
FDA
AXS-05
FDA clears US trials of Green Valley’s Alzheimer’s drug
Pharmaforum
Mon, 04/27/20 - 09:31 am
Green Valley Pharmaceuticals
China
clinical trials
FDA
Alzheimer's disease
Oligomannate
Biogen shares fall as company pushes back Alzheimer’s drug filing
MedCity News
Wed, 04/22/20 - 11:11 am
Biogen
earnings
Alzheimer's disease
aducanumab
FDA

Pages